» Articles » PMID: 7504064

An Essential Role for Interferon Gamma in Resistance to Mycobacterium Tuberculosis Infection

Overview
Journal J Exp Med
Date 1993 Dec 1
PMID 7504064
Citations 1046
Authors
Affiliations
Soon will be listed here.
Abstract

Tuberculosis, a major health problem in developing countries, has reemerged in recent years in many industrialized countries. The increased susceptibility of immunocompromised individuals to tuberculosis, and many experimental studies indicate that T cell-mediated immunity plays an important role in resistance. The lymphokine interferon gamma (IFN-gamma) is thought to be a principal mediator of macrophage activation and resistance to intracellular pathogens. Mice have been developed which fail to produce IFN-gamma (gko), because of a targeted disruption of the gene for IFN-gamma. Upon infection with Mycobacterium tuberculosis, although they develop granulomas, gko mice fail to produce reactive nitrogen intermediates and are unable to restrict the growth of the bacilli. In contrast to control mice, gko mice exhibit heightened tissue necrosis and succumb to a rapid and fatal course of tuberculosis that could be delayed, but not prevented, by treatment with exogenous recombinant IFN-gamma.

Citing Articles

Single-cell immune aging clocks reveal inter-individual heterogeneity during infection and vaccination.

Li W, Zhang Z, Kumar S, Botey-Bataller J, Zoodsma M, Ehsani A Nat Aging. 2025; .

PMID: 40044970 DOI: 10.1038/s43587-025-00819-z.


Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis.

De Voss C, Korompis M, Li S, Ateere A, McShane H, Stylianou E Front Immunol. 2025; 16:1540359.

PMID: 40018046 PMC: 11865049. DOI: 10.3389/fimmu.2025.1540359.


IFN-γ Induces Pleural Mesothelial Cells to Recruit Immune Cells via CXCL10-CXCR3 Axis in a Mouse Pleurisy Model.

Dong S, Shi X, Wu X, Yi F J Inflamm Res. 2025; 18:2521-2530.

PMID: 39995824 PMC: 11849421. DOI: 10.2147/JIR.S496037.


Oxidative stress drives potent bactericidal activity of pyrazinamide against .

Dillon N, Lamont E, Rather M, Baughn A bioRxiv. 2025; .

PMID: 39763714 PMC: 11702753. DOI: 10.1101/2024.12.17.628853.


Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals.

Lyu J, Narum D, Baldwin S, Larsen S, Bai X, Griffith D Front Immunol. 2024; 15:1427559.

PMID: 39717773 PMC: 11663721. DOI: 10.3389/fimmu.2024.1427559.


References
1.
Yamamura M, Uyemura K, Deans R, Weinberg K, Rea T, Bloom B . Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science. 1991; 254(5029):277-9. DOI: 10.1126/science.254.5029.277. View

2.
Denis M . Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol. 1991; 132(1):150-7. DOI: 10.1016/0008-8749(91)90014-3. View

3.
Denis M . Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis. J Leukoc Biol. 1991; 50(5):495-501. DOI: 10.1002/jlb.50.5.495. View

4.
Orme I, Miller E, Roberts A, Furney S, Griffin J, Dobos K . T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J Immunol. 1992; 148(1):189-96. View

5.
Kiderlen A, Kaufmann S, Lohmann-Matthes M . Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur J Immunol. 1984; 14(10):964-7. DOI: 10.1002/eji.1830141019. View